Britons sweat on CAS drug ruling
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The court of Arbitration for Sport (CAS) is to rule next week on a case between the US Olympic Committee and the International Olympic Committee that could yet open the way for sprinter Dwain Chambers and cyclist David Millar to compete at the London Olympics.
The CAS had been expected to give its decision this week but will now issue a binding judgement next Thursday. The USOC and the 400m runner LaShawn Merritt are challenging the IOC's rule that blocks athletes who have served doping bans of more than six months from competing at the Games.
The British Olympic Association bars any UK athlete who has failed a test from competing in the Games. If the CAS was to rule in favour of Merritt, who tested positive for a banned substance in a "male enhancement product", then it could result in the BOA having to alter its stance. Chambers failed in a legal challenge to the BOA before the Beijing Olympics.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments